Torrent Pharma reports a 26% net profit decline despite 42% revenue growth, while planning a ₹5,000 crore QIP. For the full story, visit the source.
Business
Torrent Pharma Q4 profit drops 26% on JB Pharma acquisition costs, severance compensation
Torrent Pharma reports a 26% net profit decline despite 42% revenue growth, while planning a ₹5,000 crore QIP.
By BL Ahmedabad Bureau· BusinessLine· 4 months ago· 2 min read

This summary is sourced from BusinessLine. Read the full article at:BusinessLine